marketcaparena
Search

    OFIX

    Orthofix Medical Inc.

    Company overview

    Market capitalization
    $400.81M
    Employees
    1,605
    Latest publication
    2026-09-29
    About Orthofix Medical Inc.

    Orthofix Medical Inc., together with its subsidiaries, operates as a medical technology company in the United States, Italy, the United Kingdom, France, Germany, Brazil, and internationally. It operates through two segments, Global Spine and Global Limb Reconstruction. The Global Spine segment manufactures, distributes, and provides support services for bone growth stimulation devices that enhance bone fusion; designs, develops, and markets a portfolio of spine fixation implant products for use throughout the spinal column; and offers bone graft substitutes, such as fiber-based and particulate demineralized bone matrices, cellular bone allografts, collagen ceramic matrices, and synthetic bone void fillers in various forms with supporting graft delivery solutions to treat various spinal, orthopedic, and dental conditions. This segment also designs, develops, and markets a portfolio of navigation technologies, including tracked surgical tools, intelligent software, and imaging equipment based on machine-vision and optical innovations; and 7D FLASH Navigation System, a navigation platform for spinal and cranial procedures. The Global Limb Reconstruction segment offers products and solutions for the underserved limb reconstruction market, including deformity correction, limb lengthening, complex fracture management, and limb preservation. This segment also designs, develops, and markets external and internal fixation limb reconstruction products that are coupled with enabling digital technologies to support the entire patient care continuum. It sells its products through distributors and sales representatives to hospitals, healthcare organizations, healthcare providers, ambulatory surgery centers, and out-patient hospitals. The company was formerly known as Orthofix International N.V. and changed its name to Orthofix Medical Inc. in July 2018. Orthofix Medical Inc. was founded in 1980 and is headquartered in Lewisville, Texas.

    Company website

    Financial statements

    Income Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ4 20252025-12-31 · USDQ2 20222022-06-30 · USDQ3 20212021-09-30 · USDQ2 20212021-06-30 · USDQ4 20202020-12-31 · USDQ3 20202020-09-30 · USDQ1 20202020-03-31 · USD
    Total Revenue210,933,000USD219,911,000USD118,070,000USD112,428,000USD121,394,000USD117,619,000USD110,985,000USD104,823,000USD
    Cost Of Revenue61,226,000USD77,881,000USD31,600,000USD28,307,000USD27,439,000USD29,071,000USD26,243,000USD23,409,000USD
    Gross Profit149,707,000USD142,030,000USD86,470,000USD84,121,000USD93,955,000USD88,548,000USD84,742,000USD81,414,000USD
    Research Development15,944,000USD15,373,000USD12,758,000USD12,360,000USD13,121,000USD10,365,000USD9,962,000USD9,964,000USD
    Selling General Administrative138,030,000USD136,753,000USD15,846,000USD16,312,000USD18,335,000USD18,495,000USD16,541,000USD17,865,000USD
    Total Operating Expenses157,841,000USD128,579,000USD79,829,000USD84,434,000USD89,688,000USD84,843,000USD80,567,000USD74,560,000USD
    Operating Income-8,134,000USD13,451,000USD6,641,000USD-313,000USD4,267,000USD3,705,000USD4,175,000USD6,854,000USD
    Total Other Income Expense Net-6,863,000USD-15,643,000USD-3,599,000USD-2,222,000USD401,000USD1,865,000USD1,086,000USD-1,221,000USD
    Net Interest Income-6,085,000USD-4,351,000USD-407,000USD-433,000USD-550,000USD-428,000USD-731,000USD-423,000USD
    Income Before Tax-14,997,000USD-2,192,000USD3,042,000USD-2,535,000USD4,668,000USD5,570,000USD5,261,000USD5,633,000USD
    Income Tax Expense801,000USD30,000USD553,000USD-364,000USD2,248,000USD14,948,000USD607,000USD-20,032,000USD
    Net Income-15,798,000USD-2,222,000USD2,489,000USD-2,171,000USD2,420,000USD-9,378,000USD4,654,000USD25,665,000USD
    Unclassified Operating Expenses—-23,547,000USD51,225,000USD——2,267,000USD1,138,000USD46,731,000USD
    Interest Expense—4,351,000USD407,000USD433,000USD550,000USD428,000USD731,000USD423,000USD
    Tax Provision—30,000USD553,000USD-364,000USD2,248,000USD14,948,000USD607,000USD-20,032,000USD
    Net Income From Continuing Ops—-2,222,000USD2,489,000USD-2,171,000USD4,668,000USD-9,378,000USD4,654,000USD25,665,000USD
    Ebit—2,159,000USD3,449,000USD-2,102,000USD5,218,000USD14,852,000USD5,992,000USD6,056,000USD
    Ebitda—91,520,000USD10,730,000USD5,915,000USD13,667,000USD24,018,000USD15,925,000USD13,388,000USD
    Depreciation And Amortization—89,361,000USD7,281,000USD8,017,000USD8,449,000USD9,166,000USD9,933,000USD7,332,000USD
    Reconciled Depreciation—15,053,000USD7,281,000USD8,017,000USD8,449,000USD9,166,000USD9,933,000USD7,332,000USD
    Non Operating Income Net Other——-3,031,000USD-1,276,000USD1,049,000USD4,174,000USD1,817,000USD-798,000USD
    Net Income Applicable To Common Shares——2,489,000USD-2,171,000USD2,420,000USD-9,378,000USD4,654,000USD25,665,000USD
    Selling And Marketing Expenses———56,097,000USD57,338,000USD53,716,000USD52,926,000USD—
    Interest Income———————423,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Income Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20182018-12-31 · USDFY 20172017-12-31 · USDFY 20162016-12-31 · USDFY 20152015-12-31 · USDFY 20142014-12-31 · USDFY 20122012-12-31 · USDFY 20112011-12-31 · USDFY 20102010-12-31 · USD
    Total Revenue453,042,000USD433,823,000USD409,788,000USD396,489,000USD402,277,000USD462,320,000USD578,988,000USD564,370,000USD
    Cost Of Revenue96,628,000USD93,037,000USD87,853,000USD86,525,000USD98,912,000USD86,492,000USD139,186,000USD131,716,000USD
    Gross Profit356,414,000USD340,786,000USD321,935,000USD309,964,000USD303,365,000USD375,828,000USD439,802,000USD432,654,000USD
    Research Development33,218,000USD29,700,000USD28,803,000USD26,389,000USD24,994,000USD28,577,000USD25,148,000USD30,350,000USD
    Selling General Administrative84,506,000USD74,388,000USD74,404,000USD87,157,000USD76,790,000USD53,827,000USD86,468,000USD88,628,000USD
    Selling And Marketing Expenses205,527,000USD198,370,000USD181,287,000USD178,080,000USD166,547,000USD200,343,000USD233,609,000USD—
    Total Operating Expenses323,251,000USD302,458,000USD284,494,000USD291,626,000USD270,615,000USD284,845,000USD350,820,000USD343,664,000USD
    Operating Income30,094,000USD40,811,000USD21,067,000USD9,255,000USD17,136,000USD89,010,000USD32,519,000USD88,990,000USD
    Interest Income828,000USD416,000USD763,000USD489,000USD————
    Interest Expense828,000USD416,000USD0USD489,000USD1,785,000USD4,161,000USD9,463,000USD17,228,000USD
    Net Interest Income-828,000USD-416,000USD763,000USD—————
    Income Before Tax22,885,000USD36,391,000USD19,024,000USD8,507,000USD12,456,000USD82,728,000USD20,703,000USD72,398,000USD
    Income Tax Expense9,074,000USD29,100,000USD15,527,000USD10,849,000USD16,200,000USD28,792,000USD21,776,000USD28,190,000USD
    Tax Provision9,074,000USD29,100,000USD15,527,000USD10,849,000USD————
    Net Income13,811,000USD6,223,000USD3,056,000USD-2,809,000USD-8,537,000USD51,295,000USD-1,073,000USD44,208,000USD
    Net Income From Continuing Ops13,811,000USD7,291,000USD3,497,000USD-2,342,000USD-3,744,000USD45,050,000USD-1,073,000USD—
    Ebit22,885,000USD40,811,000USD19,024,000USD8,996,000USD38,351,000USD75,927,000USD30,492,000USD89,626,000USD
    Ebitda41,544,000USD60,935,000USD39,865,000USD29,919,000USD40,635,000USD96,188,000USD53,268,000USD112,147,000USD
    Depreciation And Amortization18,659,000USD20,124,000USD20,841,000USD20,923,000USD2,284,000USD20,261,000USD22,776,000USD22,521,000USD
    Reconciled Depreciation18,659,000USD20,124,000USD——————
    Total Other Income Expense Net-7,209,000USD-4,420,000USD-2,043,000USD-748,000USD-4,680,000USD-7,102,000USD-33,882,000USD-10,956,000USD
    Non Operating Income Net Other-4,611,000USD-174,000USD-4,550,000USD-3,607,000USD-2,895,000USD-1,705,000USD-2,027,000USD—
    Minority Interest0USD0USD0USD0USD————
    Discontinued Operations0USD-1,068,000USD-441,000USD-467,000USD-4,793,000USD-3,557,000USD——
    Net Income Applicable To Common Shares13,811,000USD6,223,000USD3,056,000USD-2,809,000USD-8,537,000USD42,838,000USD-1,073,000USD44,208,000USD
    Unclassified Operating Expenses——————5,595,000USD224,686,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ2 20262026-06-30 · USDQ1 20262026-03-31 · USDQ4 20252025-12-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USD
    Total Assets873,020,000USD886,601,000USD850,647,000USD832,610,000USD837,157,000USD823,144,000USD893,294,000USD867,872,000USD
    Cash And Equivalents103,810,000USD———————
    Total Current Assets446,132,000USD461,520,000USD416,847,000USD394,170,000USD395,830,000USD390,310,000USD433,285,000USD386,214,000USD
    Other Current Assets21,434,000USD25,649,000USD26,757,000USD23,374,000USD27,675,000USD26,012,000USD25,882,000USD25,503,000USD
    Other Non Current Assets35,225,000USD———————
    Total Liabilities443,840,000USD———————
    Total Current Liabilities157,010,000USD161,033,000USD170,482,000USD159,847,000USD148,381,000USD144,116,000USD168,628,000USD161,898,000USD
    Other Current Liabilities93,354,000USD———————
    Other Non Current Liabilities52,336,000USD———————
    Total Stockholder Equity429,180,000USD435,186,000USD450,037,000USD442,486,000USD458,347,000USD458,294,000USD503,124,000USD525,924,000USD
    Total Equity Including Noncontrolling Interest429,180,000USD———————
    Long Term Debt221,591,000USD221,335,000USD157,391,000USD157,219,000USD157,047,000USD156,885,000USD157,015,000USD112,215,000USD
    Net Receivables135,818,000USD137,775,000USD135,746,000USD130,808,000USD129,556,000USD131,865,000USD134,713,000USD124,845,000USD
    Inventory184,475,000USD177,818,000USD172,319,000USD174,042,000USD172,993,000USD174,480,000USD189,452,000USD205,812,000USD
    Property Plant Equipment Net130,757,000USD125,327,000USD129,399,000USD153,978,000USD154,059,000USD147,288,000USD139,804,000USD146,685,000USD
    Goodwill194,934,000USD———————
    Intangible Assets65,972,000USD69,336,000USD72,765,000USD75,641,000USD78,868,000USD81,213,000USD98,803,000USD104,546,000USD
    Accounts Payable63,531,000USD54,686,000USD58,392,000USD50,459,000USD45,098,000USD45,176,000USD48,803,000USD47,060,000USD
    Common Stock4,073,000USD4,038,000USD3,983,000USD3,952,000USD3,948,000USD3,910,000USD3,849,000USD3,821,000USD
    Retained Earnings-405,039,000USD-389,241,000USD-368,333,000USD-366,111,000USD-343,316,000USD-329,235,000USD-276,141,000USD-246,995,000USD
    Accumulated Other Comprehensive Income-277,000USD142,000USD618,000USD634,000USD908,000USD-2,556,000USD-4,302,000USD-902,000USD
    Total Liab—451,415,000USD400,610,000USD390,124,000USD378,810,000USD364,850,000USD390,170,000USD341,948,000USD
    Other Current Liab—106,232,000USD108,106,000USD105,419,000USD99,438,000USD93,968,000USD106,633,000USD107,845,000USD
    Capital Stock—4,038,000USD3,983,000USD3,952,000USD3,948,000USD3,910,000USD3,849,000USD3,821,000USD
    Good Will—194,934,000USD194,934,000USD194,934,000USD194,934,000USD194,934,000USD194,934,000USD194,934,000USD
    Cash—120,278,000USD82,025,000USD65,946,000USD65,606,000USD57,953,000USD83,238,000USD30,054,000USD
    Cash And Short Term Investments—120,278,000USD82,025,000USD65,946,000USD65,606,000USD57,953,000USD83,238,000USD30,054,000USD
    Net Debt—114,109,000USD147,236,000USD138,536,000USD139,132,000USD134,806,000USD96,390,000USD107,181,000USD
    Short Term Debt—115,000USD3,984,000USD3,969,000USD3,845,000USD4,972,000USD4,778,000USD6,993,000USD
    Short Long Term Debt Total—234,387,000USD229,261,000USD204,482,000USD204,738,000USD192,759,000USD179,628,000USD137,235,000USD
    Property Plant Equipment Gross—146,898,000USD380,136,000USD153,978,000USD154,059,000USD147,288,000USD352,046,000USD—
    Common Stock Shares Outstanding—40,450,000shares40,000,000shares39,766,000shares39,500,000shares39,200,000shares38,700,000shares38,488,000shares
    Non Current Assets Total—425,081,000USD433,800,000USD438,440,000USD441,327,000USD432,834,000USD460,009,000USD481,658,000USD
    Non Current Liabilities Total—290,382,000USD230,128,000USD230,277,000USD230,429,000USD220,734,000USD221,542,000USD180,050,000USD
    Non Current Liabilities Other—31,350,000USD55,677,000USD29,764,000USD29,536,000USD32,947,000USD46,692,000USD49,808,000USD
    Non Currrent Assets Other—35,484,000USD36,702,000USD13,887,000USD13,466,000USD9,399,000USD26,468,000USD35,493,000USD
    Net Working Capital—300,487,000USD246,365,000USD234,323,000USD247,449,000USD246,194,000USD264,657,000USD224,316,000USD
    Unclassified Non Current Liabilities—37,697,000USD17,060,000USD43,294,000USD43,846,000USD30,902,000USD17,835,000USD18,027,000USD
    Unclassified Equity—816,209,000USD809,786,000USD800,059,000USD792,859,000USD782,265,000USD775,869,000USD766,179,000USD
    Unclassified Current Liabilities——————8,414,000USD-6,250,000USD
    Short Long Term Debt———————6,250,000USD
    SourceDisclosureDeterministicFinalLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Balance sheet Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Total Assets850,647,000USD893,294,000USD925,315,000USD458,629,000USD476,623,000USD525,861,000USD495,620,000USD466,641,000USD
    Intangible Assets72,765,000USD98,803,000USD117,490,000USD47,388,000USD52,666,000USD60,517,000USD54,139,000USD51,897,000USD
    Other Current Assets164,908,000USD25,882,000USD37,072,000USD22,283,000USD20,141,000USD17,030,000USD21,632,000USD20,422,000USD
    Total Liab400,610,000USD390,170,000USD326,585,000USD121,769,000USD139,689,000USD168,997,000USD167,989,000USD131,244,000USD
    Total Stockholder Equity450,037,000USD503,124,000USD598,730,000USD336,860,000USD336,934,000USD356,864,000USD327,631,000USD335,397,000USD
    Other Current Liab108,106,000USD106,633,000USD93,846,000USD47,150,000USD70,292,000USD72,670,000USD58,778,000USD64,281,000USD
    Common Stock3,983,000USD3,849,000USD3,717,000USD2,016,000USD1,983,000USD1,942,000USD1,902,000USD1,858,000USD
    Capital Stock3,983,000USD3,849,000USD3,717,000USD2,016,000USD1,983,000USD1,942,000USD1,902,000USD1,858,000USD
    Retained Earnings-368,333,000USD-276,141,000USD-150,144,000USD1,251,000USD21,000,000USD59,379,000USD57,749,000USD87,078,000USD
    Good Will194,934,000USD194,934,000USD194,934,000USD71,317,000USD71,317,000USD84,018,000USD71,177,000USD72,401,000USD
    Cash82,025,000USD83,238,000USD33,107,000USD50,700,000USD87,847,000USD96,291,000USD69,719,000USD69,623,000USD
    Cash And Short Term Investments82,025,000USD83,238,000USD33,107,000USD50,700,000USD87,847,000USD96,291,000USD69,719,000USD69,623,000USD
    Total Current Assets416,847,000USD433,285,000USD420,443,000USD255,990,000USD269,522,000USD270,379,000USD260,553,000USD244,639,000USD
    Total Current Liabilities170,482,000USD168,628,000USD165,223,000USD83,624,000USD105,830,000USD103,899,000USD84,883,000USD85,908,000USD
    Net Debt147,236,000USD96,390,000USD83,967,000USD-29,171,000USD-63,533,000USD-71,351,000USD-46,873,000USD-69,623,000USD
    Short Term Debt3,984,000USD4,778,000USD5,435,000USD2,290,000USD4,424,000USD2,602,000USD2,198,000USD0USD
    Short Long Term Debt Total229,261,000USD179,628,000USD117,074,000USD21,529,000USD24,314,000USD24,940,000USD22,846,000USD—
    Long Term Debt157,391,000USD157,015,000USD93,107,000USD————0USD
    Net Receivables135,746,000USD134,713,000USD128,098,000USD82,857,000USD78,560,000USD72,423,000USD86,805,000USD77,747,000USD
    Inventory34,168,000USD189,452,000USD222,166,000USD100,150,000USD82,974,000USD84,635,000USD82,397,000USD76,847,000USD
    Accounts Payable58,392,000USD48,803,000USD58,357,000USD27,598,000USD26,459,000USD23,118,000USD19,886,000USD17,989,000USD
    Property Plant Equipment Net-11,088,000USD139,804,000USD159,060,000USD58,229,000USD59,252,000USD63,613,000USD62,727,000USD42,835,000USD
    Property Plant Equipment Gross380,136,000USD352,046,000USD347,685,000USD221,225,000USD242,216,000USD63,613,000USD62,727,000USD42,835,000USD
    Accumulated Other Comprehensive Income618,000USD-4,302,000USD-1,293,000USD-1,376,000USD—3,252,000USD-3,039,000USD3,296,000USD
    Common Stock Shares Outstanding39,883,000shares38,134,000shares36,729,258shares20,100,000shares19,690,593shares19,391,718shares18,903,289shares18,911,610shares
    Non Current Assets Total433,800,000USD460,009,000USD504,872,000USD202,639,000USD207,101,000USD255,482,000USD235,067,000USD222,002,000USD
    Non Current Liabilities Total230,128,000USD221,542,000USD161,362,000USD38,145,000USD33,859,000USD65,098,000USD83,106,000USD45,336,000USD
    Non Current Liabilities Other55,677,000USD46,692,000USD49,723,000USD38,145,000USD33,859,000USD65,098,000USD83,106,000USD45,336,000USD
    Non Currrent Assets Other-77,440,000USD26,468,000USD33,388,000USD25,705,000USD22,095,000USD22,292,000USD11,907,000USD21,422,000USD
    Net Working Capital246,365,000USD264,657,000USD255,220,000USD172,366,000USD163,692,000USD166,480,000USD175,670,000USD158,731,000USD
    Unclassified Non Current Assets166,101,000USD-398,540,000USD—-12,833,000USD-22,095,000USD-22,292,000USD-6,109,000USD-21,422,000USD
    Unclassified Non Current Liabilities17,060,000USD17,835,000USD18,532,000USD-14,230,000USD-14,969,000USD-41,214,000USD-60,074,000USD-45,936,000USD
    Unclassified Equity809,786,000USD775,869,000USD742,733,000USD332,953,000USD311,968,000USD290,349,000USD269,117,000USD241,307,000USD
    Other Assets—398,540,000USD—12,833,000USD23,866,000USD47,334,000USD41,007,000USD54,650,000USD
    Unclassified Current Liabilities—8,414,000USD6,335,000USD6,586,000USD—-47,936,000USD4,021,000USD3,638,000USD
    Current Deferred Revenue——-1USD—4,791,000USD53,445,000USD——
    Short Long Term Debt——1,250,000USD————0USD
    Short Term Investments——-4,650,000USD————0USD
    Unclassified Current Assets——4,650,000USD—————
    Deferred Long Term Liab———700,000USD1,000,000USD1,400,000USD1,700,000USD600,000USD
    Other Liab———13,530,000USD13,969,000USD39,814,000USD58,374,000USD45,336,000USD
    Net Tangible Assets———218,155,000USD212,951,000USD212,329,000USD202,315,000USD211,099,000USD
    Long Term Investments——————219,000USD219,000USD
    Additional Paid In Capital———————0USD
    Treasury Stock———————0USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Quarterly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricQ1 20262026-03-31 · USDQ3 20252025-09-30 · USDQ2 20252025-06-30 · USDQ1 20252025-03-31 · USDQ4 20242024-12-31 · USDQ3 20242024-09-30 · USDQ2 20242024-06-30 · USDQ1 20242024-03-31 · USD
    Net Income-20,908,000USD-22,795,000USD-14,081,000USD-53,094,000USD-29,146,000USD-27,388,000USD-33,443,000USD-36,020,000USD
    Depreciation14,551,000USD14,523,000USD17,997,000USD35,682,000USD27,333,000USD16,788,000USD15,540,000USD16,340,000USD
    Stock Based Compensation6,533,000USD7,181,000USD7,824,000USD6,469,000USD7,165,000USD6,531,000USD9,959,000USD8,800,000USD
    Other Non Cash Items4,506,000USD3,830,000USD10,792,000USD14,427,000USD10,680,000USD15,498,000USD21,320,000USD13,201,000USD
    Change To Account Receivables-2,964,000USD-1,958,000USD2,710,000USD2,379,000USD-10,827,000USD591,000USD-103,000USD813,000USD
    Change To Inventory-8,845,000USD-3,579,000USD-6,583,000USD693,000USD4,274,000USD-1,249,000USD-1,635,000USD-6,936,000USD
    Change In Working Capital-22,385,000USD9,342,000USD-10,460,000USD-22,320,000USD7,320,000USD-83,000USD-5,164,000USD-21,324,000USD
    Total Cash From Operating Activities-17,610,000USD12,402,000USD11,639,000USD-18,391,000USD23,730,000USD11,671,000USD8,984,000USD-18,595,000USD
    Capital Expenditures-10,661,000USD-9,904,000USD-7,109,000USD-6,736,000USD-8,531,000USD-5,812,000USD-9,716,000USD-10,817,000USD
    Free Cash Flow-28,271,000USD2,498,000USD4,530,000USD-25,127,000USD15,199,000USD5,859,000USD-732,000USD-29,412,000USD
    Total Cashflows From Investing Activities-10,515,000USD-9,894,000USD-7,097,000USD-6,736,000USD-1,135,000USD-5,862,000USD-9,716,000USD-10,867,000USD
    Net Borrowings63,994,000USD-189,000USD-187,000USD-188,000USD29,919,000USD-179,000USD——
    Total Cash From Financing Activities63,970,000USD-5,152,000USD2,640,000USD-651,000USD31,487,000USD-2,456,000USD225,000USD21,453,000USD
    Issuance Of Capital Stock0USD36,000USD3,005,000USD49,000USD2,946,000USD120,000USD3,191,000USD0USD
    Change In Cash35,755,000USD-2,743,000USD8,236,000USD-25,285,000USD53,184,000USD3,688,000USD-598,000USD-8,293,000USD
    Begin Period Cash Flow85,115,000USD68,689,000USD60,453,000USD85,738,000USD32,554,000USD28,866,000USD29,464,000USD37,757,000USD
    End Period Cash Flow120,870,000USD65,946,000USD68,689,000USD60,453,000USD85,738,000USD32,554,000USD28,866,000USD29,464,000USD
    Other Cashflows From Investing Activities146,000USD10,000USD12,000USD—7,396,000USD-50,000USD197USD-50,000USD
    Other Cashflows From Financing Activities-24,000USD-4,999,000USD-178,000USD-512,000USD-1,378,000USD-2,397,000USD-2,792,000USD-3,375,000USD
    Investments—-9,894,000USD-7,097,000USD-6,736,000USD-1,135,000USD-5,862,000USD-9,716,000USD-10,867,000USD
    Sale Purchase Of Stock—-9,000USD———3,775,000USD-1,947,000USD-1,828,000USD
    Unclassified Investing Cash Flow—9,894,000USD7,097,000USD6,736,000USD1,135,000USD5,862,000USD9,715,803USD10,867,000USD
    Unclassified Financing Cash Flow—————-3,655,000USD4,964,000USD26,656,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Cash flow Yearly

    Exact reported values; units shown beside each amount. Missing values are —.
    MetricFY 20252025-12-31 · USDFY 20242024-12-31 · USDFY 20232023-12-31 · USDFY 20222022-12-31 · USDFY 20212021-12-31 · USDFY 20202020-12-31 · USDFY 20192019-12-31 · USDFY 20182018-12-31 · USD
    Net Income-92,192,000USD-125,997,000USD-151,395,000USD-19,749,000USD-38,379,000USD2,517,000USD-28,462,000USD13,811,000USD
    Depreciation83,255,000USD75,962,000USD60,598,000USD32,075,000USD33,095,000USD34,276,000USD24,699,000USD18,659,000USD
    Stock Based Compensation28,688,000USD32,455,000USD35,707,000USD18,443,000USD15,432,000USD16,207,000USD21,540,000USD18,930,000USD
    Other Non Cash Items34,870,000USD60,738,000USD62,722,000USD-13,386,000USD1,948,000USD-9,213,000USD42,242,000USD8,177,000USD
    Change To Account Receivables-1,583,000USD-9,526,000USD-10,411,000USD-6,735,000USD-7,049,000USD13,283,000USD-11,037,000USD-3,706,000USD
    Change To Inventory-10,748,000USD-5,546,000USD-58,051,000USD-18,133,000USD619,000USD-873,000USD-5,712,000USD9,698,000USD
    Change In Working Capital-21,497,000USD-19,251,000USD-53,964,000USD-29,235,000USD-18,103,000USD19,698,000USD-29,379,000USD-6,998,000USD
    Total Cash From Operating Activities33,347,000USD25,790,000USD-45,753,000USD-11,538,000USD18,475,000USD74,272,000USD32,033,000USD49,918,000USD
    Capital Expenditures-34,626,000USD-34,876,000USD-62,050,000USD-23,160,000USD-19,592,000USD-17,094,000USD-20,524,000USD-15,256,000USD
    Free Cash Flow-1,279,000USD-9,086,000USD-107,803,000USD-34,698,000USD-1,117,000USD57,178,000USD11,509,000USD34,662,000USD
    Investments0USD-27,580,000USD-33,131,000USD-24,534,000USD-2,171,000USD-10,000,000USD-22,924,000USD-60,998,000USD
    Total Cashflows From Investing Activities-34,598,000USD-27,580,000USD-33,131,000USD-24,534,000USD-23,013,000USD-52,334,000USD-22,924,000USD-60,998,000USD
    Net Borrowings-762,000USD54,394,000USD67,949,000USD-92,000USD-948,000USD-1,537,000USD-3,021,000USD-682,000USD
    Total Cash From Financing Activities-786,000USD50,709,000USD65,322,000USD-78,000USD-3,621,000USD3,245,000USD-10,688,000USD2,993,000USD
    Issuance Of Capital Stock5,929,000USD6,257,000USD5,127,000USD4,337,000USD8,824,000USD7,598,000USD11,551,000USD7,100,000USD
    Change In Cash-623,000USD47,981,000USD-12,943,000USD-37,147,000USD-8,974,000USD26,418,000USD-1,786,000USD-8,968,000USD
    Begin Period Cash Flow85,738,000USD37,757,000USD50,700,000USD87,847,000USD96,821,000USD70,403,000USD72,189,000USD81,157,000USD
    End Period Cash Flow85,115,000USD85,738,000USD37,757,000USD50,700,000USD87,847,000USD96,821,000USD70,403,000USD72,189,000USD
    Other Cashflows From Investing Activities28,000USD-100,000USD-500,000USD-1,374,000USD-1,250,000USD-24,334,000USD-2,400,000USD-1,448,000USD
    Other Cashflows From Financing Activities-5,953,000USD-9,942,000USD-7,754,000USD-1,821,000USD-11,908,000USD-4,030,000USD-21,874,000USD-4,107,000USD
    Unclassified Operating Cash Flow—1,883,000USD——24,482,000USD10,787,000USD1,393,000USD-2,661,000USD
    Unclassified Investing Cash Flow—34,976,000USD62,550,000USD24,534,000USD——22,924,000USD16,704,000USD
    Sale Purchase Of Stock——-4,397,000USD-1,729,000USD-2,555,000USD-2,493,000USD-5,193,000USD-3,425,000USD
    Unclassified Financing Cash Flow——9,524,000USD5,293,000USD14,345,000USD13,798,000USD24,593,000USD11,207,000USD
    Change To Liabilities———2,909,000USD5,266,000USD8,507,000USD-5,578,000USD-7,733,000USD
    Dividends Paid———-1,729,000USD-2,555,000USD-2,493,000USD-5,193,000USD0USD
    Cash And Cash Equivalents Changes———-36,150,000USD-8,159,000USD25,183,000USD-1,579,000USD-8,087,000USD
    SourceLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacyLegacy providerLegacy

    Operating metrics

    No operating metrics are currently published for this company.

    Revenue breakdown

    PeriodDimensionBusiness / regionRevenueCurrencySource
    Q2 2026Quarterly · 2026-06-30SegmentGlobal Limb Reconstruction37,690,000USDDisclosure
    Q2 2026Quarterly · 2026-06-30SegmentGlobal Spine173,243,000USDDisclosure
    Q1 2026Quarterly · 2026-03-31SegmentGlobal Limb Reconstruction32,856,000USD0001193125-26-205003
    Q1 2026Quarterly · 2026-03-31SegmentGlobal Spine163,852,000USD0001193125-26-205003
    FY 2025Yearly · 2025-12-31SegmentGlobal Limb Reconstruction134,657,000USD0001193125-26-065189
    FY 2025Yearly · 2025-12-31SegmentGlobal Spine687,655,000USD0001193125-26-065189
    Q3 2025Quarterly · 2025-09-30SegmentGlobal Orthopedics33,571,000USD0001193125-25-263670
    Q3 2025Quarterly · 2025-09-30SegmentGlobal Spine172,063,000USD0001193125-25-263670
    Q2 2025Quarterly · 2025-06-30SegmentGlobal Orthopedics33,297,000USD0000950170-25-102384
    Q2 2025Quarterly · 2025-06-30SegmentGlobal Spine169,824,000USD0000950170-25-102384
    Q1 2025Quarterly · 2025-03-31SegmentGlobal Limb Reconstruction29,810,000USD0001193125-26-205003
    Q1 2025Quarterly · 2025-03-31SegmentGlobal Spine163,836,000USD0001193125-26-205003
    Q4 2024Quarterly · 2024-12-31SegmentGlobal Orthopedics35,774,000USDLegacy provider
    Q4 2024Quarterly · 2024-12-31SegmentGlobal Spine179,883,000USDLegacy provider
    FY 2024Yearly · 2024-12-31SegmentGlobal Limb Reconstruction124,177,000USD0001193125-26-065189
    FY 2024Yearly · 2024-12-31SegmentGlobal Spine675,314,000USD0001193125-26-065189
    Q3 2024Quarterly · 2024-09-30SegmentGlobal Orthopedics30,502,000USD0001193125-25-263670
    Q3 2024Quarterly · 2024-09-30SegmentGlobal Spine166,104,000USD0001193125-25-263670
    Q2 2024Quarterly · 2024-06-30SegmentGlobal Orthopedics30,586,000USD0000950170-25-102384
    Q2 2024Quarterly · 2024-06-30SegmentGlobal Spine168,034,000USD0000950170-25-102384
    Q1 2024Quarterly · 2024-03-31GeographyInternational28,589,000USD0000950170-24-053966
    Q1 2024Quarterly · 2024-03-31GeographyUnited States160,019,000USD0000950170-24-053966
    FY 2023Yearly · 2023-12-31SegmentGlobal Limb Reconstruction115,322,000USD0001193125-26-065189
    FY 2023Yearly · 2023-12-31SegmentGlobal Spine631,319,000USD0001193125-26-065189
    Q3 2023Quarterly · 2023-09-30GeographyInternational30,760,000USD0000950170-23-061148
    Q3 2023Quarterly · 2023-09-30GeographyUnited States153,246,000USD0000950170-23-061148
    Q2 2023Quarterly · 2023-06-30GeographyInternational32,433,000USD0000950170-23-039884
    Q2 2023Quarterly · 2023-06-30GeographyUnited States154,583,000USD0000950170-23-039884
    Q1 2023Quarterly · 2023-03-31GeographyInternational29,111,000USD0000950170-24-053966
    Q1 2023Quarterly · 2023-03-31GeographyUnited States146,093,000USD0000950170-24-053966
    FY 2022Yearly · 2022-12-31SegmentGlobal Orthopedics107,539,000USD0000950170-23-006242
    FY 2022Yearly · 2022-12-31SegmentGlobal Spine — Biologics56,381,000USD0000950170-23-006242
    FY 2022Yearly · 2022-12-31SegmentGlobal Spine — Bone Growth Therapies187,247,000USD0000950170-23-006242
    FY 2022Yearly · 2022-12-31SegmentGlobal Spine — Spinal Implants109,546,000USD0000950170-23-006242
    Q3 2022Quarterly · 2022-09-30GeographyInternational25,994,000USD0000950170-23-061148
    Q3 2022Quarterly · 2022-09-30GeographyUnited States88,002,000USD0000950170-23-061148
    Q2 2022Quarterly · 2022-06-30GeographyInternational25,268,000USD0000950170-23-039884
    Q2 2022Quarterly · 2022-06-30GeographyUnited States92,802,000USD0000950170-23-039884
    Q1 2022Quarterly · 2022-03-31GeographyInternational24,025,000USD0000950170-23-019721
    Q1 2022Quarterly · 2022-03-31GeographyUnited States82,393,000USD0000950170-23-019721
    FY 2021Yearly · 2021-12-31SegmentGlobal Orthopedics105,516,000USD0000950170-23-006242
    FY 2021Yearly · 2021-12-31SegmentGlobal Spine — Biologics56,421,000USD0000950170-23-006242
    FY 2021Yearly · 2021-12-31SegmentGlobal Spine — Bone Growth Therapies187,448,000USD0000950170-23-006242
    FY 2021Yearly · 2021-12-31SegmentGlobal Spine — Spinal Implants115,094,000USD0000950170-23-006242
    Q3 2021Quarterly · 2021-09-30GeographyInternational26,435,000USD0000950170-22-021538
    Q3 2021Quarterly · 2021-09-30GeographyUnited States85,993,000USD0000950170-22-021538
    FY 2020Yearly · 2020-12-31SegmentGlobal Orthopedics84,827,000USD0000950170-23-006242
    FY 2020Yearly · 2020-12-31SegmentGlobal Spine — Biologics55,482,000USD0000950170-23-006242
    FY 2020Yearly · 2020-12-31SegmentGlobal Spine — Bone Growth Therapies171,396,000USD0000950170-23-006242
    FY 2020Yearly · 2020-12-31SegmentGlobal Spine — Spinal Implants94,857,000USD0000950170-23-006242
    FY 2019Yearly · 2019-12-31SegmentGlobal Orthopedics102,734,000USD0001564590-22-006929
    FY 2019Yearly · 2019-12-31SegmentGlobal Spine — Biologics65,496,000USD0001564590-22-006929
    FY 2019Yearly · 2019-12-31SegmentGlobal Spine — Bone Growth Therapies197,181,000USD0001564590-22-006929
    FY 2019Yearly · 2019-12-31SegmentGlobal Spine — Spinal Implants94,544,000USD0001564590-22-006929
    FY 2018Yearly · 2018-12-31SegmentGlobal Extremities106,448,000USD0001564590-21-009214
    FY 2018Yearly · 2018-12-31SegmentGlobal Spine — Biologics59,684,000USD0001564590-21-009214
    FY 2018Yearly · 2018-12-31SegmentGlobal Spine — Bone Growth Therapies195,252,000USD0001564590-21-009214
    FY 2018Yearly · 2018-12-31SegmentGlobal Spine — Spinal Implants91,658,000USD0001564590-21-009214
    FY 2016Yearly · 2016-12-31GeographyBR11,334,000USD0001564590-18-003256
    FY 2016Yearly · 2016-12-31GeographyItaly16,664,000USD0001564590-18-003256
    FY 2016Yearly · 2016-12-31GeographyOther Countries54,555,000USD0001564590-18-003256
    FY 2016Yearly · 2016-12-31GeographyUnited Kingdom10,362,000USD0001564590-18-003256
    FY 2016Yearly · 2016-12-31GeographyUnited States316,873,000USD0001564590-18-003256
    FY 2015Yearly · 2015-12-31GeographyBR13,512,000USD0001564590-18-003256
    FY 2015Yearly · 2015-12-31GeographyItaly15,655,000USD0001564590-18-003256
    FY 2015Yearly · 2015-12-31GeographyOther Countries50,441,000USD0001564590-18-003256
    FY 2015Yearly · 2015-12-31GeographyUnited Kingdom11,376,000USD0001564590-18-003256
    FY 2015Yearly · 2015-12-31GeographyUnited States305,505,000USD0001564590-18-003256
    FY 2014Yearly · 2014-12-31GeographyBR19,633,000USD0001564590-17-002569
    FY 2014Yearly · 2014-12-31GeographyItaly19,573,000USD0001564590-17-002569
    FY 2014Yearly · 2014-12-31GeographyOther Countries56,987,000USD0001564590-17-002569
    FY 2014Yearly · 2014-12-31GeographyUnited Kingdom11,402,000USD0001564590-17-002569
    FY 2014Yearly · 2014-12-31GeographyUnited States294,682,000USD0001564590-17-002569
    FY 2013Yearly · 2013-12-31GeographyBR26,786,000USD0001564590-16-013722
    FY 2013Yearly · 2013-12-31GeographyItaly16,755,000USD0001564590-16-013722
    FY 2013Yearly · 2013-12-31GeographyOther Countries51,036,000USD0001564590-16-013722
    FY 2013Yearly · 2013-12-31GeographyUnited Kingdom10,002,000USD0001564590-16-013722
    FY 2013Yearly · 2013-12-31GeographyUnited States293,032,000USD0001564590-16-013722
    FY 2012Yearly · 2012-12-31GeographyBR31,166,000USD0001564590-15-003012
    FY 2012Yearly · 2012-12-31GeographyItaly18,742,000USD0001564590-15-003012
    FY 2012Yearly · 2012-12-31GeographyOther Countries54,622,000USD0001564590-15-003012
    FY 2012Yearly · 2012-12-31GeographyUnited Kingdom8,431,000USD0001564590-15-003012
    FY 2012Yearly · 2012-12-31GeographyUnited States327,228,000USD0001564590-15-003012
    FY 2011Yearly · 2011-12-31GeographyBR34,424,000USD0001193125-14-122624
    FY 2011Yearly · 2011-12-31GeographyItaly17,447,000USD0001193125-14-122624
    FY 2011Yearly · 2011-12-31GeographyOther Countries53,309,000USD0001193125-14-122624
    FY 2011Yearly · 2011-12-31GeographyUnited Kingdom8,206,000USD0001193125-14-122624
    FY 2011Yearly · 2011-12-31GeographyUnited States328,585,000USD0001193125-14-122624

    Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.